India's Serum Institute to partner with Gates Foundation to make COVID-19 vaccine
BENGALURU (Reuters) - The Serum Institute of India said it will partner with the Bill & Melinda Gates Foundation and international vaccine alliance GAVI to manufacture and deliver 100 million COVID-19 vaccine doses for India and other low- and middle-income nations as early as 2021.
The institute said on Friday it will get funding to support manufacturing for candidate vaccines from AstraZeneca and Novavax.
(Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Ramakrishnan M.)
© Copyright Reuters Ltd. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Reuters Ltd.